UNSPSC 51412100: Vasodilator benzimidazoles

Vasodilator drugs made from compounds with a benzene fused to imidazoles.

UNSPSC 51412100 Vasodilator benzimidazoles, a Class code, captures state and local procurement of emergency medications and pharmaceutical products for fire rescue, health agencies, and multi-jurisdictional cooperative purchasing programs. Recent solicitations show that state and local buyers use this code to procure specific medication formulations — including labetalol, diltiazem, epinephrine, and adenosine — for emergency medical services delivery, pharmacy benefit programs, and distributed healthcare facility supply chains. Issuing bodies span city purchasing departments (the City of Tampa), state health agencies (Texas Health and Human Services Commission), and regional cooperative purchasing alliances (Minnesota Multistate Cooperative Purchasing Alliance, serving multiple state and local jurisdictions including Oregon). The scope reflects both direct-supply arrangements for emergency responders and wholesale-channel distribution agreements where state and local governments specify products, NDC codes, pricing models, and compliance requirements including Good Manufacturing Practices certification, Drug Supply Chain Security Act compliance, FDA conformance, and OSHA Safety Data Sheet standards.

Activity appears concentrated in Texas, Florida, and Minnesota, with cooperative purchasing mechanisms extending geographic reach across multiple states and jurisdictions. Representative recent opportunities include the City of Tampa's IFB for Advanced Life Support Medications (Solicitation 26P00188, due April 8, 2026, estimated value $40,000) supplying labetalol, epinephrine, adenosine, and diltiazem vials to Tampa Fire Rescue with a one-year contract term and renewal options; the Texas HHS Commission's RFI (HHS0017013, closed April 3, 2026) exploring direct-to-manufacturer prescription programs to inform future formal solicitation strategy; and the Minnesota Department of Administration's RFP through MMCAP (S1070000015802, due March 26, 2026) establishing multi-award contracts for generic pharmaceuticals and OTC products distributed via AmerisourceBergen, Cardinal Health, and Morris & Dickson, effective July 1, 2026, with a two-year initial term. Tampa's solicitation includes a 5 percent Small Local Business Enterprise bid discount (not to exceed $10,000) and accessibility and compliance documentation requirements. The code shows active state and local procurement momentum in emergency medical services supply and multi-jurisdictional pharmacy benefit contracting.